Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence - Scorecard - MDSpire

Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence

  • By

  • August 7, 2025

  • 3 min

Share

Clinical Scorecard: Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence

At a Glance

CategoryDetail
ConditionBlood cancers including leukemia, lymphoma, and multiple myeloma
Key MechanismsHematopoietic stem cell transplantation (allogeneic and autologous)
Target PopulationPatients with blood-based cancers
Care SettingTransplant & Cellular Therapy Center

Key Highlights

  • 100% six-month survival rate for adults who received transplants in 2024
  • Roswell Park has performed over 3,450 transplants since 1977
  • Recognized as a Center of Excellence by Optum for clinical expertise and patient outcomes
  • Enhanced outpatient care and reduced hospital stay for transplants
  • Innovative protocols for stem cell donor selection

Guideline-Based Recommendations

Diagnosis

  • Assessment of blood cancers for eligibility of stem cell transplantation

Management

  • Utilization of allogeneic or autologous hematopoietic stem cell transplantation

Monitoring & Follow-up

  • Regular follow-up for patient outcomes post-transplant

Risks

  • Potential complications associated with stem cell transplantation

Patient & Prescribing Data

Adults and pediatric patients with blood cancers

Outpatient care models are being implemented to enhance recovery

Clinical Best Practices

  • Early patient engagement and assessment for transplantation
  • Adoption of research-based protocols for donor selection
  • Focus on personalized care throughout the transplant process

References

Original Source(s)

Related Content